Results 201 to 210 of about 641,694 (264)

Targeting PLD3 Reverses the Immunosuppressive Niche by Reprogramming Tumor‐Associated Macrophages and Potentiates Antitumor Immunity

open access: yesAdvanced Science, EarlyView.
PLD3 activates the lysosomal‐AKT‐NF‐κB axis to drive cellular senescence in macrophages, establishing an immunosuppressive TME by limiting the infiltration of cytotoxic T, NK, and NKT cells, which confers resistance to anti‐PD‐1 therapy. Abrine inhibits PLD3 expression, restoring antitumor immunity and synergizing with anti‐PD‐1 treatment.
Xingtu Qin   +11 more
wiley   +1 more source

Author Correction: LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation

open access: yesCell Discovery
Rundong Jiang   +14 more
doaj   +1 more source

mTORC2 Phosphorylation of GSDME‐N Drives Cullin4B‐Mediated Proteasomal Degradation to Suppress Pyroptosis and Confer Radioresistance in Small Cell Lung Cancer

open access: yesAdvanced Science, EarlyView.
Radioresistance severely limits the efficacy of therapies for small cell lung cancer (SCLC). This study reveals a novel mechanism of resistance driven by the active suppression of pyroptosis. Specifically, the mTORC2 complex directly phosphorylates GSDME‐N and promotes its CUL4B‐mediated ubiquitination and proteasomal degradation.
Qing‐qing Xu   +11 more
wiley   +1 more source

Rates of Self-Reported Skin Cancer in Current and Retired Elite Australian Cricketers. [PDF]

open access: yesAustralas J Dermatol
Orchard JW   +6 more
europepmc   +1 more source

Hypergraph-based contrastive embedding and attention fusion for detection of skin cancer. [PDF]

open access: yesSci Rep
Banerjee T   +5 more
europepmc   +1 more source

Multimodal models for skin cancer classification using clinical freetext and dermatoscopic images. [PDF]

open access: yesCommun Med (Lond)
Watson M   +8 more
europepmc   +1 more source

Editorial: Genetics and epigenetics of melanoma and non-melanoma skin cancer. [PDF]

open access: yesFront Genet
Moltrasio C   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy